Barclays
NVO

Barclays’s Novo Nordisk NVO Stock Holding History

Barclays’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121M Buy
3,283,636
+2,333,364
+246% +$111M 0.03% 437
2025
Q4 		$48.3M Buy
950,272
+89,309
+10% +$4.57M 0.01% 796
2025
Q3 		$47.8M Buy
860,963
+232,108
+37% +$13.6M 0.01% 795
2025
Q2 		$43.4M Buy
628,855
+204,656
+48% +$13.9M 0.01% 768
2025
Q1 		$29.5M Sell
424,199
-623,101
-59% -$51.5M 0.01% 857
2024
Q4 		$90.1M Buy
1,047,300
+605,681
+137% +$65.5M 0.03% 430
2024
Q3 		$52.6M Buy
441,619
+186,525
+73% +$24.9M 0.01% 649
2024
Q2 		$36.4M Sell
255,094
-67,379
-21% -$8.93M 0.01% 720
2024
Q1 		$41.4M Buy
322,473
+277,306
+614% +$33M 0.01% 680
2023
Q4 		$4.67M Buy
45,167
+27,473
+155% +$2.72M ﹤0.01% 2158
2023
Q3 		$1.61M Sell
17,694
-9,842
-36% -$867K ﹤0.01% 2017
2023
Q2 		$2.23M Buy
27,536
+21,206
+335% +$1.73M ﹤0.01% 1819
2023
Q1 		$504K Buy
6,330
+330
+6% +$23.4K ﹤0.01% 3272
2022
Q4 		$406K Hold
6,000
– – ﹤0.01% 3440
2022
Q3 		$299K Sell
6,000
-140,704
-96% -$7.54M ﹤0.01% 2976
2022
Q2 		$8.17M Buy
146,704
+20,440
+16% +$1.13M 0.01% 1096
2022
Q1 		$7.01M Buy
126,264
+61,368
+95% +$3.15M 0.01% 1068
2021
Q4 		$3.63M Sell
64,896
-10,160
-14% -$550K ﹤0.01% 1943
2021
Q3 		$3.6M Buy
75,056
+64,862
+636% +$3.14M ﹤0.01% 1856
2021
Q2 		$427K Sell
10,194
-12,094
-54% -$469K ﹤0.01% 3158
2021
Q1 		$751K Sell
22,288
-30,000
-57% -$1.07M ﹤0.01% 2945
2020
Q4 		$1.83M Buy
52,288
+50,004
+2,189% +$1.73M ﹤0.01% 2301
2020
Q3 		$80K Sell
2,284
-1,006
-31% -$33.5K ﹤0.01% 4360
2020
Q2 		$107K Sell
3,290
-37,134
-92% -$1.18M ﹤0.01% 4470
2020
Q1 		$1.22M Sell
40,424
-192,586
-83% -$5.73M ﹤0.01% 2755
2019
Q4 		$6.74M Buy
233,010
+170,860
+275% +$4.73M ﹤0.01% 1729
2019
Q3 		$1.61M Buy
62,150
+61,148
+6,103% +$1.55M ﹤0.01% 3131
2019
Q2 		$25K Sell
1,002
-31,196
-97% -$771K ﹤0.01% 6360
2019
Q1 		$842K Sell
32,198
-101,118
-76% -$2.49M ﹤0.01% 3600
2018
Q4 		$3.07M Sell
133,316
-89,432
-40% -$1.99M ﹤0.01% 1986
2018
Q3 		$5.25M Sell
222,748
-106,328
-32% -$2.59M ﹤0.01% 1769
2018
Q2 		$7.59M Buy
329,076
+263,660
+403% +$6.27M 0.01% 1424
2018
Q1 		$1.61M Sell
65,416
-65,556
-50% -$1.72M ﹤0.01% 2702
2017
Q4 		$3.52M Sell
130,972
-792
-0.6% -$20.1K ﹤0.01% 1932
2017
Q3 		$3.17M Buy
131,764
+103,958
+374% +$2.35M ﹤0.01% 1893
2017
Q2 		$596K Hold
27,806
– – ﹤0.01% 3350
2017
Q1 		$476K Sell
27,806
-34,824
-56% -$606K ﹤0.01% 3446
2016
Q4 		$1.12M Buy
62,630
+50,036
+397% +$907K ﹤0.01% 2637
2016
Q3 		$262K Sell
12,594
-9,234
-42% -$229K ﹤0.01% 3734
2016
Q2 		$587K Sell
21,828
-11,404
-34% -$313K ﹤0.01% 3074
2016
Q1 		$898K Buy
+33,232
New +$890K ﹤0.01% 2611
2015
Q4 		– Sell
-50,456
Closed -$1.4M – 6400
2015
Q3 		$1.36M Buy
50,456
+33,294
+194% +$943K ﹤0.01% 2446
2015
Q2 		$465K Sell
17,162
-92,302
-84% -$2.59M ﹤0.01% 3532
2015
Q1 		$2.9M Buy
109,464
+36,136
+49% +$832K ﹤0.01% 1979
2014
Q4 		$1.54M Buy
73,328
+45,890
+167% +$1.03M ﹤0.01% 2770
2014
Q3 		$645K Buy
27,438
+13,740
+100% +$316K ﹤0.01% 3732
2014
Q2 		$315K Buy
13,698
+4,712
+52% +$104K ﹤0.01% 4401
2014
Q1 		$203K Sell
8,986
-183,934
-95% -$3.92M ﹤0.01% 4783
2013
Q4 		$3.55M Buy
192,920
+92,270
+92% +$1.61M ﹤0.01% 2098
2013
Q3 		$1.7M Buy
100,650
+71,050
+240% +$1.19M ﹤0.01% 2777
2013
Q2 		$459K Buy
+29,600
New +$493K ﹤0.01% 4310

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Barclays's NVO Position: Q1 2026 in Review

Barclays increased its Novo Nordisk (NVO) stake by 246% in Q1 2026, buying an estimated $111M and bringing the position to 3,283,636 shares worth $121M. The position accounts for 0.03% of the portfolio, ranked #437.

Barclays first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Barclays held 3,283,636 shares of Novo Nordisk worth $121M as of Q1 2026.
  • Barclays bought 2,333,364 Novo Nordisk shares in Q1 2026, an estimated $111M.
  • Novo Nordisk made up 0.03% of Barclays's portfolio in Q1 2026, its #437 holding.
  • Barclays first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.